Teva agrees to settlement in price-fixing case in the US
Israel-based drugmaker agrees to pay a $225 million fine to settle price-fixing charges related to three of its medicines.
Israel-based drugmaker agrees to pay a $225 million fine to settle price-fixing charges related to three of its medicines.
Israel-based drugmaker agrees to pay Nevada to settle claims that its marketing practices fueled opioid addiction.
Israeli drugmaker reaches settlement worth $225 million to resolve claims it fueled an opioid epidemic in Texas.
Israeli drug-maker investigated by over whether it illegally hindered rivals’ access to its multiple sclerosis medicine.
Teva chief says company in talks with COVID-19 vaccine makers to co-produce some shots.
European Commission says Teva was in breach of rules after it effectively agreed with another company to keep a cheaper drug off the market.
US Justice Department charges Teva of illegally fixing drug prices between 2013 and 2015.
Former Teva executives will pay shareholders $50 million in compensation for fines the co. was forced to pay for bribery charges.
Head of struggling pharmaceutical giant refuses to budge after government demands Jerusalem factories remain open, offers to train employees
'Our factory is a ticking time bomb' say employees of pharmaceutical giant Teva. 'We have access to explosives and poison - so be prepared.'
Large part of Israeli services to grind to a halt as general strike aims at stopping pharmaceutical giant Teva from firing 1,700 workers.
Employees burn tires, block roads as pharmaceutical giant seeks to cut 14,000 jobs.
Netanyahu speaks with CEO of Teva Pharmaceutical Industries, amidst company's reported intention to cut thousands of workers in Israel.
Histadrut to hold nationwide strike on Sunday following reports that troubled drug giant will cut thousands of jobs.
Teva Pharmaceuticals reportedly to unveil program cutting over 4,000 jobs, mainly in Israel and the US.
Teva lays off thousands of workers, closes six factories, after losing $6 billion.
Teva to lay off some of its 7,000 employees in Israel it reorganizes.
Teva Pharmaceutical expected to name Pascal Soriot as its next CEO, reports say.
Erez Vigodman, CEO of Israeli generic drugmaker, resigns amid the company's recent stumbles.
Israeli generic drug giant Teva will pay $519 million to settle charges that it paid bribes to foreign officials to win business.
Teva Pharmaceutical Industries to become the first major medical company to market and distribute a cannabis inhaler.
Teva Pharmaceutical completes $40 billion acquisition of the generics arm of rival Allergan.
Israeli pharmaceutical company wins regulatory approval for acquisition of Allergan, conditional upon giving up some of its products.
Experts disagree as to whether the tech world in Israel is capable of maturing to the level where a tech giant such as Google can exist.
$40.5 billion purchase solidifies Teva as world leader in generic drugs, after $40.1 billion bid for rival Mylan meets resistance.
Israeli pharma giant to pay for illegal monopoly 'pay for delay' move made by company Cephalon - before Teva acquired it.
Consulting job to the tune of $10,000 per month reportedly on the table; details have not been finalized.
$40 billion acquisition of US company would launch Teva to unprecedented size - but will its bid be accepted?
Chairman Phillip Frost's announcement the latest in a string of abrupt changes in major Israeli company.
A U.S. Supreme Court Justice gave a green light for competitors of Teva to sell generic versions of multiple sclerosis drug Copaxone.
Teva on Thursday named Erez Vigodman, 54, as new CEO of the company, after last October's controversial resignation of Dr. Jeremy Levin.
Teva will pay Pfizer a royalty for a license to produce its generic version, from late 2017.
Teva said Monday that it would return tens billions of shekels to Israel from abroad, and pay a tax bill of nearly three billion shekels.
Jeremy Levin resigns from the pharmaceutical giant amid tensions in the company
After meeting with Histadrut chairman, pharmaceutical giant promises it will coordinate layoff plans.
Finance Minister says he has spoken to Teva's CEO and asked him to reduce the number of employees the company lays off.
Pharmaceutical firm will reduce global manpower by 10%; 700-800 layoffs expected in Israel.
American Jew Dr. Jeremy Levin was named new CEO for Teva Pharmaceuticals Monday, when Shlomo Yanai announced he is stepping down.
Eli Hurvitz, who served as CEO of Teva Pharmaceutical Industries until 2002, passes away from a serious illness.
Two Israeli-based firms try out a peptide aimed at stopping Type 1 diabetes at its source and eliminate the need for insulin injections.
A new treatment for lymphoma, a type of cancer, has passed its Phase II clinical trial. CT-011 is produced by CureTech, a Teva company.
Israel’s Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, has dedicated its new, $100 million distribution center.
Teva Pharmaceuticals enjoys the approval of two new generics by the US Food and Drug Administration, stocks rise.
Israeli pharmaceutical giant Teva has won the bid to acquire German generic drug maker Ratiopharm for $4.9 billion.
Israeli-based TEVA has been called a juggernaut, copy-cat and an 800-pound ape. It makes generic drugs, lots of them, and money – lots of it.
Israeli pharmaceutical giant Teva has signed a deal to invest $60 million in a new cancer-fighting drug to fight prostate and lung cancer.